Effectiveness of azvudine versus nirmatrelvir/ritonavir for hospitalized patients with SARS-CoV-2 infection and pre-existing liver diseases

被引:0
|
作者
Guanyue Su [1 ]
Feng Gao [1 ]
Mengzhao Yang [1 ]
Ling Wang [2 ]
Lili Liang [3 ]
Silin Li [4 ]
Guangming Li [5 ]
Na Han [1 ]
Guotao Li [6 ]
Guowu Qian [7 ]
Shixi Zhang [8 ]
Hong Luo [9 ]
Donghua Zhang [10 ]
Hongxia Liang [1 ]
Zhigang Ren [1 ]
机构
[1] the First Affiliated Hospital of Zhengzhou University,Department of Infectious Diseases, State Key Laboratory of Antiviral Drugs, Pingyuan Laboratory
[2] Henan Provincial Chest Hospital Affiliated of Zhengzhou University,Department of Clinical Laboratory
[3] Henan Provincial Chest Hospital Affiliated of Zhengzhou University,Department of Medical Information
[4] Fengqiu County People’s Hospital,Department of Respiratory and Critical Care Medicine
[5] the Affiliated Infectious Disease Hospital of Zhengzhou University,Department of Liver Disease
[6] Luoyang Central Hospital Affiliated of Zhengzhou University,Department of Infectious Diseases
[7] Nanyang Central Hospital,Department of Gastrointestinal Surgery
[8] Shangqiu Municipal Hospital,Department of Infectious Diseases
[9] Guangshan County People’s Hospital,Department of Infectious Diseases
[10] Guangshan County,undefined
[11] Anyang City Fifth People’s Hospital,undefined
关键词
SARS-CoV-2; Azvudine; Paxlovid; Chronic liver disease; Effectiveness;
D O I
10.1186/s12985-025-02771-1
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Long-term antibody response to inactivated SARS-CoV-2 vaccination in patients with chronic liver disease: A multicenter study
    Yang, Yinuo
    Li, Xuemei
    Zhao, Xinya
    Liu, Yiqing
    Zhao, Tong
    Zhu, Qiang
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (07)
  • [42] SARS-CoV-2 Vaccine Uptake among Patients with Chronic Liver Disease: A Cross-Sectional Analysis in Hebei Province, China
    Liu, Yongmei
    Yuan, Wenfang
    Zhan, Haoting
    Kang, Haiyan
    Li, Xiaomeng
    Chen, Yongliang
    Li, Haolong
    Sun, Xingli
    Cheng, Linlin
    Zheng, Haojie
    Wang, Wei
    Guo, Xinru
    Li, Yongzhe
    Dai, Erhei
    VACCINES, 2023, 11 (08)
  • [43] Effectiveness of a Second Dose of an mRNA Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in Individuals Previously Infected by Other Variants
    Monge, Susana
    Rojas-Benedicto, Ayelen
    Olmedo, Carmen
    Martin-Merino, Elisa
    Mazagatos, Clara
    Limia, Aurora
    Jose Sierra, Maria
    Larrauri, Amparo
    Hernan, Miguel A.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E367 - E374
  • [44] Real-world effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection among adolescents (12 to 17-year-olds) in Malaysia
    Husin, Masliyana
    Tok, Peter Seah Keng
    Suah, Jing Lian
    Thevananthan, Thevesh
    Tng, Boon Hwa
    Peariasamy, Kalaiarasu M.
    Sivasampu, Sheamini
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 121 : 55 - 57
  • [45] Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
    Arabi, Maryam
    Al-Najjar, Yousef
    Sharma, Omna
    Kamal, Ibtihal
    Javed, Aimen
    Gohil, Harsh S.
    Paul, Pradipta
    Al-Khalifa, Aljazi M.
    Laws, Sa'ad
    Zakaria, Dalia
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [46] Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
    Maryam Arabi
    Yousef Al-Najjar
    Omna Sharma
    Ibtihal Kamal
    Aimen Javed
    Harsh S. Gohil
    Pradipta Paul
    Aljazi M. Al-Khalifa
    Sa’ad Laws
    Dalia Zakaria
    BMC Infectious Diseases, 23
  • [47] High Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Associated With Decreased Contact Tracing Effectiveness for Identifying Persons at Elevated Risk of Infection-Vermont
    Borah, Brian F.
    Pringle, Julia
    Flaherty, Michael
    Oeltmann, John E.
    Moonan, Patrick K.
    Kelso, Patsy
    CLINICAL INFECTIOUS DISEASES, 2022, 75 : S334 - S337
  • [48] Short-term effectiveness of single-dose intranasal spray COVID-19 vaccine against symptomatic SARS-CoV-2 Omicron infection in healthcare workers: a prospective cohort study
    Mi, Hongfei
    Chen, Qi
    Lin, Hongyan
    He, Tingjuan
    Zhang, Ruixin
    Ren, Shuhao
    Liu, Lingling
    Wang, Jing
    Huang, Hua
    Wang, Meixia
    Guo, Zhinan
    Su, Chenghao
    ECLINICALMEDICINE, 2024, 67
  • [49] Efficacy and safety of inactivated SARS-CoV-2 vaccination in COVID-19-associated pneumonia among patients with rheumatic and musculoskeletal diseases: A real-world retrospective observational study
    Liu, Shuman
    Jin, Ziyi
    Feng, Xuebing
    Da, Zhanyun
    Tang, Yu
    Hu, Huaixia
    Wang, Dandan
    Sun, Lingyun
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (05)
  • [50] Real-world effectiveness of Yindan Jiedu granules-based treatment on patients infected with the SARS-CoV-2 Omicron variants BA.2 combined with high-risk factors: A cohort study
    Feng, Ying
    Liu, Yao
    Liu, Long
    Liu, Yao
    Jiang, Yuyong
    Hou, Yixin
    Zhou, Yang
    Song, Rui
    Chen, Xiaoyou
    Wang, Xianbo
    FRONTIERS IN PHARMACOLOGY, 2022, 13